Bioholography Research & Development

the company is based in france. the scope: development and wide implementation of principally new technology useful for any cancer screening. a single test (accuracy > 85%) distinguishes persons with and without malignant processes. non-costly, non-invasive, short-term, user-friendly and automatable system is sensitive for cancerous processes disregarding their type, stage or location. more information can be found here: 1. marina shaduri and marc bouchoucha (2013). life-cycling of cancer: new concept, cancer treatment - conventional and innovative approaches, prof. letícia rangel (ed.), isbn: 978-953-51-1098-9, intech, available from: http://www.intechopen.com/books/cancer-treatment-conventional-and-innovative-approaches/life-cycling-of-cancer-new-concept 2. marina shaduri. the holographic principle and emergence phenomenon, holography, research and technologies, joseph rosen (ed.), isbn: 978-953-307-227-2, intech. available from: http://www.intechopen.com/articles/show/title/the-holo